AzTrials
AzTrials

Professional BurnoutADA modelNCT01039168

Return to Work After a Workplace-oriented Intervention for Patients on Sick Leave Due to Burnout

A study testing Workplace dialogue and Care as usual in people with Professional Burnout, run by Region Skane at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to evaluate the effect on return to work of a workplace intervention with patients being treated for burnout. The intervention intends to reduce job-person mismatch through patient-supervisor communication.The hypothesis is that the intervention group will show a more favourable outcome than a control… Read more about this study

Who is it for?
Ages Up to 63 years
Conditions the study is for
Professional Burnout
What is being tested?
Workplace dialogue and Care as usual
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
76 participants
Where
1 siteSweden
Study dates
Nov 2003to Sep 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 63 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • employment
  • sick leave at lest half time 2-6 months due to work related burnout
  • previously healthy

Who cannot join

  • other somatic or psychiatric disease explaining the symptoms

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Occupational and Environmental Medicine, Lund University Hospital

    Lund, 22185

Other trials in Sweden

About this study

Official title: Reduction of Person-job Mismatch to Increase Work Capacity, by Education of, and Dialogue Between Involved Parties - Evaluation of an Intervention Program

The study aims to evaluate the effect on return to work of a workplace intervention with patients being treated for burnout. The intervention intends to reduce job-person mismatch through patient-supervisor communication.The hypothesis is that the intervention group will show a more favourable outcome than a control group with respect to return to work.

Read the detailed description

Participants are consecutively recruited in co-operation with regional social insurance offices (RSIOs) in the two southern counties of Sweden. Persons accepting participation are clinically examined and interviewed of the course of events leading up to the burnout and the patient's expectations of changes necessary to facilitate return to work are recorded. The patient´s supervisor is then interviewed at the workplace, responding to the same questions on perceived main causes of the subordinate's sick leave and changes necessary to facilitate return to work. Finally, the core intervention takes place, namely a dialogue being initiated between the patient and the supervisor to find solutions to facilitate return to work. Out of those who do not want to participate, without giving any specific reason for that, a control group is matched by length and degree of sick leave at the time of the intervention.

Being tested
Workplace dialogue, Care as usual
Keywords
Burnout, Sick leave, Intervention study, Prospective study, Work
Medical subject headings
Burnout, Professional, Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Workplace dialogueBehavioural

  • Care as usualOther

Study groups in NCT01039168
Study groupRoleWhat they receive
Workplace dialogueActive comparatorClinical examination and dialogue with supervisor to find solutions to reduce job-person mismatch and facilitate return to work
Receives: Behavioral: Workplace dialogue
Care as usualSham comparatorNo intervention besides of the care as usual being available for the patient
Receives: Other: Care as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to work from sick leave

    Measured: Up to 1,5 years post intervention completion

Secondary outcomes (1)
  1. Self-rated health measures (only in the intervention group)

    Measured: Up to 1,5 years post intervention completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2009 (estimated)
  2. Study startNov 2003
  3. Primary completionSep 2009
  4. Study completionSep 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01039168
Sponsor's protocol ID
FAS 2003-0765
Acronym
ADA model
Status last verified
Mar 2024
First submitted
22 Dec 2009
Last updated
15 Mar 2024
Results posted
No
Data monitoring committee
No

Publications

  • Karlson B, Jonsson P, Palsson B, Abjornsson G, Malmberg B, Larsson B, Osterberg K. Return to work after a workplace-oriented intervention for patients on sick-leave for burnout--a prospective controlled study. BMC Public Health. 2010 Jun 2;10:301. doi: 10.1186/1471-2458-10-301.

    PubMed 20515510

Questions about this trial

What is this clinical trial studying?

A study testing Workplace dialogue and Care as usual in people with Professional Burnout, run by Region Skane at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to work from sick leave (time frame: Up to 1,5 years post intervention completion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01039168, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in